Abstract
THE response of the rat pituitary gland to oestrogen includes increased mitotic and secretory activity affecting several of the cell types in the anterior lobe but leading in particular to proliferation of prolactin cells1. Bromocryptine inhibits release of prolactin2,3 and also inhibits DNA synthesis in the oestrogen-stimulated pituitary gland4. In studying the pituitary response to oestrogen during a prolonged period of bromocryptine inhibition, we have observed a close relationship between effects on serum prolactin levels and on pituitary mitotic activity. Our findings lend support to the idea that secretory behaviour influences mitotic activity in prolactin cells4.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Gersten, B. E., and Baker, B. L., Am. J. Anat., 128, 1–20 (1970).
Pasteels, J. L., Danguy, A., Frerotte, M., and Ectors, F., Annls Endocr., 32, 188–192 (1971).
Shaar, C. J., and Clemens, J. A., Endocrinology, 90, 285–288 (1972).
Davies, C., Jacobi, J., Lloyd, H. M., and Meares, J. D., J. Endocr., 61, 411–417 (1974).
Lemay, A., and Labrie, F., FEBS Lett., 20, 7–10 (1972).
Nagasawa, H., and Yanai, R., J. Endocr., 55, 215–216 (1972).
Masui, H., and Garren, L. D., Proc. natn. Acad, Sci. U.S.A., 68, 3206–3210 (1971).
Burger, M. M., Bombik, B. M., Breckenridge, B. McL., and Sheppard, J. R., Nature, 239, 161–163 (1972).
Hymer, W. C., Mastro, A., and Griswold, E., Science, 167, 1629–1631 (1970).
Meites, J., and Clemens, C. W., Vitam. Horm., 30, 165–221 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LLOYD, H., MEARES, J. & JACOBI, J. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells. Nature 255, 497–498 (1975). https://doi.org/10.1038/255497a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/255497a0
This article is cited by
-
Management of medically refractory prolactinoma
Journal of Neuro-Oncology (2014)
-
Involvement of insulin-like growth factor-I for the regulation of prolactin synthesis by estrogen and postnatal proliferation of lactotrophs in the mouse anterior pituitary
Cell and Tissue Research (2010)
-
Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline
Pituitary (2008)
-
Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists
Acta Neuropathologica (2006)
-
Pharmacologic Resistance in Prolactinoma Patients
Pituitary (2005)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
